Literature DB >> 15679866

Effect of stem cell mobilization with cyclophosphamide plus granulocyte colony-stimulating factor on morphology of haematopoietic organs in mice.

P Szumilas1, K Barcew, M Baśkiewicz-Masiuk, B Wiszniewska, M Z Ratajczak, B Machaliński.   

Abstract

Both granulocyte colony-stimulating factor (G-CSF) and cyclophosphamide (CY) are employed in the clinic as mobilizing agents to stimulate the egress of haematopoietic stem/progenitor cells (HSPC) from bone marrow (BM) into peripheral blood (PB). However, although both compounds are effective, the simultaneous administration of G-CSF + CY allows for optimal mobilization. The aim of this study was to compare morphological changes in major haematopoietic organs in mice mobilized by G-CSF + CY. We employed the standard G-CSF + CY mobilization protocol, in which mice were injected at day 0 with a single dose of CY followed by daily injection of G-CSF for 6 consecutive days. We noticed that the cytoreductive effect of CY on BM and spleen tissue was compensated at day 2 by the pro-proliferative effect of G-CSF. Furthermore, as evidenced by histological examination of BM sections at day 4, egress of haematopoietic cells from BM was accelerated by 2 days as compared to mobilization by G-CSF or CY alone; also, by day 6 there was accumulation of early haematopoietic (Thy-l(low) c-kit+) cells in the spleens and livers of mobilized animals. This implies that HSPC that are mobilized from BM and circulate in PB may 'home' to peripheral organs. We envision that such an accumulation of these cells in the spleen (which is a major haematopoietic organ in mouse) allows them to participate in haematopoietic reconstitution. Their homing to other sites (for example the liver) is evidence that BM-derived stem cells are playing a pivotal role in organ/tissue regeneration. The potential involvement of major chemoattractants for stem cells, like stromal-derived factor-1 which is induced by CY in various regenerating organs such as the liver, requires further study. We conclude that inclusion of CY into mobilization protocols on the one hand efficiently increases the egress of HSPC from the BM, but on the other hand may lead to the relocation of BM stem cell pools to peripheral tissues.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15679866      PMCID: PMC6496524          DOI: 10.1111/j.1365-2184.2005.00329.x

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  42 in total

1.  CXCR-4 desensitization is associated with tissue localization of hemopoietic progenitor cells.

Authors:  H Shen; T Cheng; I Olszak; E Garcia-Zepeda; Z Lu; S Herrmann; R Fallon; A D Luster; D T Scadden
Journal:  J Immunol       Date:  2001-04-15       Impact factor: 5.422

2.  Predictive value of circulating immature cell counts in peripheral blood for timing of peripheral blood progenitor cell collection after G-CSF plus chemotherapy-induced mobilization.

Authors:  Teruhiko Kozuka; Kazuma Ikeda; Takanori Teshima; Kensuke Kojima; Keitaro Matsuo; Akihiro Bessho; Kazutaka Sunami; Yasushi Hiramatsu; Yoshinobu Maeda; Toshio Noguchi; Kazuhiko Yamamoto; Nobuharu Fujii; Toshi Imai; Katsuto Takenaka; Katsuji Shinagawa; Fumihiko Ishimaru; Kenji Niiya; Norio Koide; Mitsune Tanimoto; Mine Harada
Journal:  Transfusion       Date:  2002-11       Impact factor: 3.157

Review 3.  Hepatic stem cells.

Authors:  Stuart Forbes; Pamela Vig; Richard Poulsom; Howard Thomas; Malcolm Alison
Journal:  J Pathol       Date:  2002-07       Impact factor: 7.996

4.  Hemopoietic effects of short-term in vivo treatment of mice with various doses of rhG-CSF.

Authors:  Z Pojda; G Molineux; T M Dexter
Journal:  Exp Hematol       Date:  1990-01       Impact factor: 3.084

Review 5.  Embryonic hematopoiesis in mice and humans.

Authors:  M C Yoder
Journal:  Acta Paediatr Suppl       Date:  2002

6.  Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1.

Authors:  G A McQuibban; G S Butler; J H Gong; L Bendall; C Power; I Clark-Lewis; C M Overall
Journal:  J Biol Chem       Date:  2001-09-24       Impact factor: 5.157

7.  Response of hematopoiesis to cyclophosphamide follows highly specific patterns in bone marrow and spleen.

Authors:  Ludĕk Sefc; Oskar Psenák; Viktor Sýkora; Karel Sulc; Emanuel Necas
Journal:  J Hematother Stem Cell Res       Date:  2003-02

8.  Current mechanistic scenarios in hematopoietic stem/progenitor cell mobilization.

Authors:  Thalia Papayannopoulou
Journal:  Blood       Date:  2003-11-06       Impact factor: 22.113

9.  Prominent role of TGF-beta 1 in thrombopoietin-induced myelofibrosis in mice.

Authors:  Hédia Chagraoui; Emiko Komura; Micheline Tulliez; Stéphane Giraudier; William Vainchenker; Françoise Wendling
Journal:  Blood       Date:  2002-07-05       Impact factor: 22.113

10.  G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4.

Authors:  Isabelle Petit; Martine Szyper-Kravitz; Arnon Nagler; Meir Lahav; Amnon Peled; Liliana Habler; Tanya Ponomaryov; Russell S Taichman; Fernando Arenzana-Seisdedos; Nobutaka Fujii; Judith Sandbank; Dov Zipori; Tsvee Lapidot
Journal:  Nat Immunol       Date:  2002-06-17       Impact factor: 25.606

View more
  12 in total

Review 1.  Neural regulation of hematopoiesis, inflammation, and cancer.

Authors:  Maher Hanoun; Maria Maryanovich; Anna Arnal-Estapé; Paul S Frenette
Journal:  Neuron       Date:  2015-04-22       Impact factor: 17.173

2.  Mobilised bone marrow-derived cells accelerate wound healing.

Authors:  Yu Wang; Yu Sun; Xiao-Yan Yang; Shi-Zhao Ji; Shu Han; Zhao-Fan Xia
Journal:  Int Wound J       Date:  2012-06-27       Impact factor: 3.315

Review 3.  Current Developments in Mobilization of Hematopoietic Stem and Progenitor Cells and Their Interaction with Niches in Bone Marrow.

Authors:  Rudolf Richter; Wolfgang Forssmann; Reinhard Henschler
Journal:  Transfus Med Hemother       Date:  2017-05-29       Impact factor: 3.747

4.  CXCL12 secretion by bone marrow stromal cells is dependent on cell contact and mediated by connexin-43 and connexin-45 gap junctions.

Authors:  Amir Schajnovitz; Tomer Itkin; Gabriele D'Uva; Alexander Kalinkovich; Karin Golan; Aya Ludin; Dror Cohen; Ziv Shulman; Abraham Avigdor; Arnon Nagler; Orit Kollet; Rony Seger; Tsvee Lapidot
Journal:  Nat Immunol       Date:  2011-03-27       Impact factor: 25.606

5.  Mobilization-based chemotherapy-free engraftment of gene-edited human hematopoietic stem cells.

Authors:  Attya Omer-Javed; Gabriele Pedrazzani; Luisa Albano; Sherash Ghaus; Claire Latroche; Maura Manzi; Samuele Ferrari; Martina Fiumara; Aurelien Jacob; Valentina Vavassori; Alessandro Nonis; Daniele Canarutto; Luigi Naldini
Journal:  Cell       Date:  2022-05-25       Impact factor: 66.850

Review 6.  Cellular players of hematopoietic stem cell mobilization in the bone marrow niche.

Authors:  Joshua Tay; Jean-Pierre Levesque; Ingrid G Winkler
Journal:  Int J Hematol       Date:  2016-12-10       Impact factor: 2.490

7.  Wiskott-Aldrich syndrome protein-deficient hematopoietic cells can be efficiently mobilized by granulocyte colony-stimulating factor.

Authors:  Sabine Charrier; Michael Blundell; Gregory Cédrone; Fawzia Louache; William Vainchenker; Adrian J Thrasher; Anne Galy
Journal:  Haematologica       Date:  2013-02-26       Impact factor: 9.941

8.  Granulocyte-colony stimulating factor promotes liver repair and induces oval cell migration and proliferation in rats.

Authors:  Anna C Piscaglia; Thomas D Shupe; Seh-Hoon Oh; Antonio Gasbarrini; Bryon E Petersen
Journal:  Gastroenterology       Date:  2007-05-21       Impact factor: 22.682

9.  [Effect of cyclophosphamide on hematopoietic stem cells in mice with iron overload].

Authors:  Yanjun Xu; Tiantian Yi; Xiaoxiao Xu; Fuyu Pei; Yuelin He; Xuedong Wu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2020-01-30

10.  Cyclophosphamide induces bone marrow to yield higher numbers of precursor dendritic cells in vitro capable of functional antigen presentation to T cells in vivo.

Authors:  Mohamed L Salem; Sabry A El-Naggar; David J Cole
Journal:  Cell Immunol       Date:  2009-12-05       Impact factor: 4.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.